Aeluma CEO’s 10b5‑1 Sales Surge: Over 3 Million Shares Sold, Stock Slumps 51% YoY, Investors Question Insider Confidence
CEO Jonathan Klamkin’s recent 10b5‑1 sale of 100,000 Aeluma shares at $10.53 raises concerns over insider confidence and could pressure the stock’s already volatile valuation.
3 minutes to read